Juva-019 and Juva-042, non-cannabinoid compounds discovered by the researchers at Juva Life, prove the medical benefit of cannabis goes beyond cannabinoids.

Chronic inflammation is the root cause of dozens of diseases and conditions. However, modern medicine and pharmaceuticals aren’t always the best solutions. In 2020, drug overdoses reached an all-time high of 93,000 deaths. All across the world, researchers are looking for alternatives to NSAIDs and deadly opioid-based medicines.

With fingers in almost every aspect of the legal cannabis industry, Doug Chloupek has a long, extensive history in the world of cannabis. Today, as the CEO and Founder of Juva Life, Chloupek, and his team of researchers, have discovered new, non-cannabinoid compounds in cannabis that may provide a significant breakthrough in inflammation control.

Cannabis Tech reached out to Chloupek to talk about the discoveries and their patient research registry that works to collect qualified data from the patients directly.